Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Health Innovation Journal

And How Stakeholders Can, Literally, Save the World

Climate change will be the biggest impact on global health. The healthcare industry may not respond in time.

Director, Marsh & McLennan Advantage Insights
Partner, Health and Life Sciences, Oliver Wyman

Specialty drugs represent an opportunity to better serve patients, but also pose risks.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Actuarial, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare

Q&A with the Academy of Nutrition and Dietetics on malnutrition's greatest challenges and opportunities

What if your doctor handed out grocery lists, not a grocery list of pills to take?

Chief Science Officer, Academy of Nutrition and Dietetics
Director, Oliver Wyman Health Innovation Center, Oliver Wyman

Physicians are best positioned to curtail the $265 billion wasted annually on unneeded care.

Global Head, Health Services, Oliver Wyman
Professor of Surgery and Health Policy, Johns Hopkins Medicine
Principal, Health and Life Sciences, Oliver Wyman

Those challengers who address critical patient needs beyond traditional treatment will become a force to be reckoned with.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman